Andreas Seidl
Chief Tech/Sci/R&D Officer chez FORMYCON AG
Profil
Andreas Seidl is currently the Chief Operating Officer at LEUKOCARE AG and the Chief Scientific Officer at Formycon AG.
He holds a doctorate degree from Universität Konstanz.
Postes actifs de Andreas Seidl
| Sociétés | Poste | Début |
|---|---|---|
| FORMYCON AG | Chief Tech/Sci/R&D Officer | 01/07/2022 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Chief Operating Officer | 01/04/2019 |
Formation de Andreas Seidl
| Universität Konstanz | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
